Christoph Peter

15PUBLICATIONS
40CO-AUTHORS
ChemotherapyPredictive and prognostic markersMedical biochemistry - amino acids and metabolitesMetabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 27, 2026
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1.

|May 26, 2025
Highly elevated sepsis biomarkers in advanced cholangiocarcinoma without sepsis: A case report and literature review.

Bianca Karnuth, Almut Brundert, Claus Langer

|Jan 22, 2025
Towards routine high-throughput analysis of fecal bile acids: validation of an enzymatic cycling method for the quantification of total bile acids in human stool samples on fully automated clinical chemistry analyzers.

Angelique Masetto, Tina Leber, Tobias Frömel

|Nov 28, 2024
Performance evaluation of enzymatic total bile acid (TBA) routine assays: systematic comparison of five fifth-generation TBA cycling methods and their individual bile acid recovery from HPLC-MS/MS reference.

Matthias Grimmler, Tobias Frömel, Angelique Masetto

|Jun 11, 2024
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs).

Laura Schmitt, Julia Hoppe, Pablo Cea-Medina

|Mar 09, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2.

Laura Schmitt, Ilka Lechtenberg, Daniel Drießen

Pageof 3

Frequent Collaborators

7 joint publications

Björn Stork

6 joint publications

Matthias Grimmler

4 joint publications

Sebastian Wesselborg

3 joint publications

Karina S Krings